May 8 | 2019
2cureX publishes interim report for the first quarter of 2019
Read more
May 8 | 2019
2cureX offentliggör delårsrapport för det första kvartalet 2019
Read more
May 7 | 2019
2cureX publishes the annual report for the fiscal year 2018
Read more
May 7 | 2019
2cureX offentliggör årsredovisning för räkenskapsåret 2018
Read more
April 24 | 2019
2cureX decides on rights issue prior to market launch of IndiTreat®
Read more
April 24 | 2019
2cureX beslutar om företrädesemission inför marknadslansering av IndiTreat®
Read more
April 4 | 2019
2cureX offentliggör kommersiellt samarbete med Gibson Oncology, USA
Read more
April 4 | 2019
2cureX announces commercial collaboration with Gibson Oncology, USA
Read more
April 2 | 2019
Communique from extraordinary general meeting of 2cureX AB (publ)
Read more
April 2 | 2019
Kommuniké från extra bolagsstämma i 2cureX AB (publ)
Read more
March 28 | 2019
2cureX receives Notice of Allowance from the United States Patent Office
Read more
March 28 | 2019
2cureX erhåller Notice of Allowance från det amerikanska patentverket
Read more
March 14 | 2019
Notice of extraordinary general meeting in 2cureX AB (publ)
Read more
March 14 | 2019
Kallelse till extra bolagsstämma i 2cureX AB (publ)
Read more
March 12 | 2019
2cureX utvidgar verksamheten till förebyggande cancermedicin
Read more
March 12 | 2019
2cureX expands its activities to preventive cancer medicine
Read more
March 1 | 2019
2cureX offentliggör bokslutskommuniké för räkenskapsåret 2018
Read more
March 1 | 2019
2cureX publishes year-end report for the fiscal year 2018
Read more